NeuroSense receives US patent for Alzheimer's treatment through 2043
Go back to NeuroSense receives US patent for Alzheimer's treatment through 2043| (NASDAQ: NRSN) | Delayed: 0.39 +0.01 (2.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.38 | 52 Week High | $ | |||
| Open | $0.39 | 52 Week Low | $ | |||
| Day High | $0.42 | P/E | N/A | |||
| Day Low | $0.37 | EPS | $ | |||
| Volume | 182,862 | |||||
| (NASDAQ: NRSNW) | Delayed: 0.04 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.04 | 52 Week High | $ | |||
| Open | $0.04 | 52 Week Low | $ | |||
| Day High | $0.04 | P/E | N/A | |||
| Day Low | $0.04 | EPS | $ | |||
| Volume | 1,089 | |||||
